-

Milliman Medical Index: Healthcare costs for an American family reach $37,824 in 2026

2026 marks highest healthcare cost increase in more than a decade, as GLP-1 drugs and AI-enabled billing emerge as new drivers

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., the premier global consulting and actuarial firm, today announced the release of the 2026 Milliman Medical Index (MMI), which measures healthcare costs for Americans covered by a typical employer-sponsored health insurance plan. Healthcare costs for the average person rose 7.9% in 2026 to $8,460—the highest annual increase in more than a decade, excluding pandemic-era fluctuations. Healthcare costs for the MMI’s hypothetical family of four reached $37,824. Outpatient facility costs rose 7.5% and pharmacy costs rose 14.8%, with those two service categories accounting for 69% of the total year-over-year increase.

"Pharmacy costs have been a persistent driver of healthcare cost growth for several years now, but 2026 represents an acceleration of the trend," says Milliman Principal and Consulting Actuary Andrew Timcheck. "A 14.8% increase in pharmacy costs—driven by GLP-1 utilization and high-cost specialty drugs—combined with continued outpatient facility cost growth, puts the 2026 trend environment in a category of its own for this decade."

"The 7.9% increase we are seeing this year is not the result of a single acute shock—it reflects structural forces that are not going away," says Milliman Principal and Consulting Actuary Deana Bell. "Outpatient costs have quadrupled for the MMI’s family of four since the MMI was first published in 2005, with much of the trend exacerbated by delivery system consolidation, specialty drug growth, and site-of-care shifts.”

"For the first time in the MMI's history, we're flagging artificial intelligence as a factor in healthcare cost trends," says Milliman Principal and Consulting Actuary Jason Clarkson. "Hospitals are using AI to optimize their billing and claim coding, and payers are using it to enhance their claim adjudication processes, especially for detecting fraud, waste, and abuse. That dynamic is worth watching as costs hit their highest growth rate in over a decade."

To read the 2026 Milliman Medical Index, visit milliman.com/en/insight/2026-milliman-medical-index.

About Milliman

Milliman leverages deep expertise, actuarial rigor, and advanced technology to develop solutions for a world at risk. We help clients in the public and private sectors navigate urgent, complex challenges—from extreme weather and market volatility to financial insecurity and rising health costs—so they can meet their business, financial, and social objectives. Our solutions encompass insurance, financial services, healthcare, life sciences, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

Contacts

Jeremy Engdahl-Johnson
Milliman, Inc.
Tel: +1 646.473.3021
Jeremy.engdahl-johnson@milliman.com

Milliman, Inc.


Release Versions

Contacts

Jeremy Engdahl-Johnson
Milliman, Inc.
Tel: +1 646.473.3021
Jeremy.engdahl-johnson@milliman.com

More News From Milliman, Inc.

90 Degree Benefits Selects Milliman SkySail to Optimize Pharmacy Benefit Management

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a leading global actuarial and consulting firm, today announced that 90 Degree Benefits has selected Milliman SkySail® to provide comprehensive pharmacy benefit management (PBM) consulting services.90 Degree Benefits has expanded rapidly in recent years, becoming one of the ten largest TPAs in the United States. As pharmacy costs continue to increase at an alarming rate, the need for a sophisticated, independent pharmacy benefit advisor has become increa...

Milliman AG 55 implementation survey finds life insurers moving quickly to address new reinsurance testing expectations

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today announced the results of its Actuarial Guideline LV1 (AG 55) life insurance industry survey, which examined how companies are responding to new asset adequacy testing expectations for certain reinsurance arrangements. The survey included responses from 23 companies, with 22 reporting that they were in scope for AG 55 testing. The results show that the industry has moved quickly toward cash flow testi...

Milliman analysis: Multiemployer pensions' aggregate funding level reaches 106% at midyear 2026, highest in study history

SEATTLE--(BUSINESS WIRE)--Milliman analysis: Multiemployer pensions' aggregate funding level reaches 106% at midyear 2026, highest in study history...
Back to Newsroom